Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Firdapse for Severe Botulism
NCT01441557Phase 3Completed
- Sponsor
- CHU Amiens-Picardie
- Start
- Sep 2011
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amifampridine in botulism, sponsored by CHU Amiens-Picardie. Started Sep 2011; status: completed.
02
Drugs
amifampridine
03
Conditions
botulism
Beyond the preview
Go deeper on NCT01441557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01441557.